DNA/RNA Synthesis

RNA synthesis, which is also called DNA transcription, is a highly selective process. Transcription by RNA polymerase II extends beyond RNA synthesis, towards a more active role in mRNA maturation, surveillance and export to the cytoplasm.

Single-strand breaks are repaired by DNA ligase using the complementary strand of the double helix as a template, with DNA ligase creating the final phosphodiester bond to fully repair the DNA.DNA ligases discriminate against substrates containing RNA strands or mismatched base pairs at positions near the ends of the nickedDNA. Bleomycin (BLM) exerts its genotoxicity by generating free radicals, whichattack C-4′ in the deoxyribose backbone of DNA, leading to opening of the ribose ring and strand breakage; it is an S-independentradiomimetic agent that causes double-strand breaks in DNA.

First strand cDNA is synthesized using random hexamer primers and M-MuLV Reverse Transcriptase (RNase H). Second strand cDNA synthesis is subsequently performed using DNA Polymerase I and RNase H. The remaining overhangs are converted into blunt ends using exonuclease/polymerase activity. After adenylation of the 3′ ends of DNA fragments, NEBNext Adaptor with hairpin loop structure is ligated to prepare the samples for hybridization. Cell cycle and DNA replication are the top two pathways regulated by BET bromodomain inhibition. Cycloheximide blocks the translation of mRNA to protein.

共 2776种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
(+)-Plakevulin A

(+)-Plakevulin A (Plakevulin A) 是一种可从冲绳海绵 Plakortis sp 中分离得到的氧脂素,能抑制 DNA 聚合酶(pols)α 和 δ 的酶活性,诱导细胞凋亡 (apoptosis),并具有抗癌活性。

518035-27-3
Inhibitor
(+)-Plakevulin A
(+)-TK216

(+)-TK216 是 TK216 (MS-A86417) 的对映异构体,而 TK216 是一种口服有效的 E26 转录因子 (ETS) 抑制剂。

1903783-77-6
Inhibitor
98.87%
(+)-TK216
(-)-Enitociclib
(R)-Enitociclib; (-)-BAY-1251152; (-)-VIP152

(-)-Enitociclib ((R)-Enitociclib) 是 Enitociclib 的旋光性为 (-) 的对映体,而 Enitociclib 是一种选择性 CDK9 抑制剂和凋亡 (apoptosis) 诱导剂,通过抑制 CDK9 活性减少 RNA 聚合酶 Pol II 羧基末端结构域 (CTD) 丝氨酸2 (Ser2) 的磷酸化,从而下调 MYC、MCL1 等关键致癌基因的转录,具有靶向 MYC+ 淋巴瘤和多发性骨髓瘤 (MM) 细胞的抗增殖活性,并与 Bortezomib (MS-D47138)、Lenalidomide (MS-O60836) 具有协同作用,可用于血液系统恶性肿瘤研究。

1610408-96-2
Inhibitor
99.85%
(-)-Enitociclib
(-)-Enitociclib (Standard)
(R)-Enitociclib (Standard); (-)-BAY-1251152 (Standard); (-)-VIP152 (Standard)

(-)-Enitociclib (Standard) 是 (-)-Enitociclib (MS-F24910) 的分析标准品,本产品用于研究及分析应用,其中 (-)-Enitociclib ((R)-Enitociclib) 是 Enitociclib 的对映体,旋光性为 (-),而 Enitociclib 是一种选择性 CDK9 抑制剂和凋亡 (apoptosis) 诱导剂,通过抑制 CDK9 活性减少 RNA 聚合酶 Pol II。

1610408-96-2
Inhibitor
(-)-Enitociclib (Standard)
(-)-TK216

(-)-TK216 是 TK216 (MS-A86417) 的对映异构体,而 TK216 是一种口服有效的 E26 转录因子 (ETS) 抑制剂,因此 (-)-TK216 具有抗癌作用。

1903783-78-7
Inhibitor
99.45%
(-)-TK216
(2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl isopropyl diisopropylphosphoramidite

(2R,3R,4R,5R)-2-((双(4-甲氧基苯基)(苯基)甲氧基)甲基)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-4-氟四氢呋喃-3-基异丙基二异丙基磷酰胺是一种可用于寡核苷酸合成的亚磷酰胺单体。

(2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl isopropyl diisopropylphosphoramidite
N-Nitrosonornicotine-d4
(2S)-N'-Nitrosonornicotine-d4

N-Nitrosonornicotine-d4((2S)-N'-Nitrosonornicotine-d4)是氘代标记的 N-Nitrosonornicotine;N-Nitrosonornicotine 是一种具有致癌活性和致突变性的烟草特异性亚硝胺,可在 C3A 细胞中诱导微核,并能形成 DNA 加合物。

1426174-36-8
(2S)-N'-亚硝基降烟碱-d4
(3S,17S)-FD-895

(3S,17S)-FD-895 是 FD-895 (MS-E74197) 的类似物,属于剪接体调节剂,可抑制癌细胞生长并具有基因选择性剪接调控活性,可用于结直肠癌的研究。

2598242-04-5
(3S,17S)-FD-895
Benzyl (5-hydroxypentyl)carbamate
(5-羟基戊基)氨基甲酸苄酯

Benzyl (5-hydroxypentyl)carbamate 是一种连接剂,可通过结合糖骨架上的 5'-羟基来修复受损 DNA,还可与 DNA 配体结合并抑制抗性细胞系中的细胞增殖,但它对细胞具有毒性,也会导致 DNA 损伤和链断裂。

87905-98-4
(5-羟基戊基)氨基甲酸苄酯
(E)-(Dimethylamino)methylene-2'-F-dG-CE phosphoramidite

(2R,3R,4R,5R)-2-((双(4-甲氧基苯基)(苯基)甲氧基)甲基)-5-(2-(((E)-(二甲基氨基)亚甲基)氨基)-6-氧代-3,6-二氢-9H-嘌呤-9-基)-4-氟四氢呋喃-3-基(2-氰基乙基)二异丙基亚磷酰胺是一种亚磷酰胺单体,可用于寡核苷酸的合成。

3081868-42-7
(E)-(Dimethylamino)methylene-2'-F-dG-CE phosphoramidite
(E)-3-AP
(E)-PAN-811; (E)-NSC# 663249; (E)-OCX191

(E)-3-AP 是 3-AP 的 E 构型,而 3-AP 是一种有效的核糖核苷酸还原酶抑制剂,具有抗增殖活性,在 L1210 白血病模型中显示出抗癌活性,并可抑制 RR 活性和 DNA 合成。

200933-27-3
Inhibitor
99.24%
(E)-3-AP
(E)-5-(2-Bromovinyl)pyrimidine-2,4(1H,3H)-dione
(E)-5-(2-Bromovinyl)uracil; BVU

(E)-5-(2-Bromovinyl)pyrimidine-2,4(1H,3H)-dione((E)-5-(2-Bromovinyl)uracil;BVU)是一种嘧啶碱基,是抗病毒药物索利夫定和(E)-5-(2-溴乙烯基)-2'-脱氧尿苷(BVDU)的无活性代谢物,可在体内再生为BVDU,并以NADPH依赖的方式不可逆地灭活二氢嘧啶脱氢酶(DPD);当以200 μmol/kg的剂量给药时,它可增强化疗药物和DPD底物5-氟尿嘧啶在P388鼠白血病模型中的疗效,从而延长生存时间。

69304-49-0
Inhibitor
(E)-5-(2-溴乙烯基)嘧啶-2,4(1H,3H)-二酮

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础